How Different Sedatives Affect Hip Fracture Patient's Postoperative Delirium

Delirium in Old Age Clinical Trial

Official title:

Influence on Incidence of Postoperative Delirium by Various Sedatives in Elderly Patients With Hip Fracture Under Lumbar Anesthesia: A Randomized, Control and Multi-center Trial

Clinical Trial Details — Status: Not yet recruiting

Administrative data

• NCT number: NCT03346226
• Other study ID #: Postoperative Delirium
• Status: Not yet recruiting
• Phase: Phase 4
• First received: September 14, 2017
• Last updated: December 11, 2017
• Start date: January 1, 2018
• Est. completion date: June 30, 2019

Study information

• Verified date: December 2017
• Source: Shanghai Zhongshan Hospital
• Contact: Zhang XiaoGuang, Doctor
• Phone: +86 13641995733
• Email: zhangxg[@]fudan.edu.cn
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

the hypothesis is that Dexmedetomidine seems to decrease incidence of post-operative delirium . one possible mechanism is that Dex have a minor influence on cognition, since it has no effect on GABA receptor，another is that Dex could induce a sleep similar to natural sleep, thereby decreasing sleep deprivation and circadian rhythm disorder in post-operative patients.

In this study , investigators devise the two different sedatives(Dexmedetomidine and Propofol)'influence on postoperative delirium in hip fracture elderly participants under spinal anesthesia

Description:

With a complex etiology, delirium is usually caused by various peri-operative stimuli on basis of predisposing factors, including senility, hypoxia and hypotension, pain, drug (such as pethidine, benzodiazepine, anticholinergic, and drug withdrawal), complications prior to surgery, post-operative sleep disorder. As for the mechanism of delirium, the commonly accepted hypothesis includes the decreased central cholinergic neurons function and the inflammation of central nervous system. Most of the hip fracture patients are senile, suffering generally from many complications with exposure to many drugs, and poor in nutritional status with decreased cognitive function even before the surgery in some of them, all of which are risk factors for post-operative delirium. Systematic review suggests that incidence of POD in patients undergoing elective hip arthroplasty is up to 4-53.3%. It is of great importance, therefore, to explore the effective approaches to lower POD incidence in senile patients with operation on hip fracture.

Dexmedetomidine Hydrochloride is a novel highly-selective α2 adrenergic receptor agonist, and its selectivity to α2 receptor is 8 times of that of clonidine. It has multiple functions including sedation, anti-anxiety, hypnosis, analgesia and sympathetic blockade, with a wide application prospect for peri-operative patients. Researches suggest that Dex applied peri-operatively may stabilize blood pressure and heart rate, control intra-operative stress, and decrease post-operative side reactions such as nausea, vomiting, restlessness, delirium and chills. Moreover, advantages of Dex also include analgesia and reduction of opioid usage. Clinical pharmacological characteristics of Dex suggest its possible function to decrease post-operative delirium. Meanwhile, Dex seems to have a minor influence on cognition, since it has no effect on GABA receptor.

Another important feature of it is that Dex induces a sleep similar to natural sleep, thereby decreasing sleep deprivation and circadian rhythm disorder in post-operative patients, and decreasing incidence of post-operative delirium. Researches evaluating the capability of Dex to decrease delirium incidence are focused on ICU sedation post to operation. Riker et al compared the sedative effect between Dex and midazolam in patients with severe mechanical ventilation, revealing a lower delirium incidence in Dex than in midazolam (54.0% vs 76.6%) in patients maintained with the same depth of sedation. Systematic review concludes that Dex in effective to prevent and treat post-operative delirium in ICU patients.

In this study ,the investigators devise the two different sedatives (Dexmedetomidine and Propofol)'influence on postoperative delirium in hip fracture elderly participants under spinal anesthesia

Recruitment information / eligibility

• Status: Not yet recruiting
• Enrollment: 1000
• Est. completion date: June 30, 2019
• Est. primary completion date: December 30, 2018
• Accepts healthy volunteers: No
• Gender: All
• Age group: 65 Years to 90 Years

Eligibility

Inclusion Criteria:

1. Acquisition of informed consent,

2. Patients with hip fracture surgery under lumbar anesthesia,

3. Grade II to III based on American Society of Anesthesiologists ASA classification,

4. Age =65 and =90 years old.

Exclusion Criteria:

1. History of psychiatric disease or a disease needing long-term exposure to psychotropic drugs (dementia, schizophrenia), or history of alcoholic abuse.

2. More than 8 errors in preoperative Simplified Psychology and Mental Status Questionnaire (SPMSQ) , and diagnosed as severe cognitive impairment.

3. CAM positive diagnosed preoperatively.

4. Any cerebrovascular accident occurring within 3 months, such as cerebral stroke or transient ischemic attack (TIA).

5. Systolic pressure < 90mmHg and diastolic pressure < 60mm Hg at the preoperative follow up or HR< 50/minute.

6. History of heat failure or EF<30% as shown by ultrasound cardiogram; degree 2 type 2 and degree 3 atrioventricular block. History of active heart disease (such as acute cardiac infarction, unstable angina pectoris)

7. Severe abnormality in hepatic or renal function (severe abnormality in liver function:

more than 2-times increase than upper normal limit in any one of the markers including ALT,, conjugated bilirubin, AST, ALP, total bilirubin; severe abnormality in renal function; Cr clearance<30ml/min), Scr>443µmol/L.

8. Diabetes patients with severe complications of diabetes (Diabetic ketoacidosis, hyperosmolar coma, various infections, macrovascular diseases, and diabetic nephropathy)

9. Patients with severe infection.

10. Postoperative PaO2<60mmHg or SpO2<92%.

11. Participation in clinical trials of other drugs within past 30 days.

12. Disturbed verbal communication, and unable to accomplish the test on cognition.

13. Patients with prosthesis fracture or restoration; hip fracture but complicated with severe trauma in other sites.

14. Being allergic to investigational drug or having contradiction of lumbar anesthesia.

Related Conditions & MeSH terms

• Delirium
• Delirium in Old Age
• Hip Fractures

Intervention

Drug:
• Dexmedetomidine Hydrochloride
Dexmedetomidine is given to patients during spinal anesthesia at the dose of 0.5 µg/kg,adjusted the dose to keep BIS between 70-80 until 30 minutes before the end of surgery
• Propofol
Propofol is given with an initial ratio of 2-10mg/kg/h, when the operation starts,adjust the propofol`s dose to keep BIS between 70-80 before the end of surgery

Locations

Country	Name	City	State
n/a

Sponsors (13)

Lead Sponsor

Collaborator

Shanghai Zhongshan Hospital

Beijing Jishuitan Hospital, First Affiliated Hospital of Guangxi Medical University, Foshan Hospital of Traditional Chinese Medicine, Qianfoshan Hospital, Second Hospital of Shanxi Medical University, Shanghai 6th People's Hospital, Shanghai Changzheng Hospital, Tang-Du Hospital, The First Affiliated Hospital of Nanchang University, The First Affiliated Hospital of Soochow University, The Fuzhou No 2 Hospital, The Second Affiliated Hospital of Harbin Medical University

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	occurrence of postoperative delirium in postoperative 72 hours	Evaluation of delirium is performed by trained investigational assistant who does not know the randomization of patients. Follow up is carried out before operation and at 9Am and 3Pm during post-operative day 1-3 (POD1-3). During follow up, RASS (Richmond Agitation-Sedation Scale, RASS) is used firstly to evaluate sedation of the patients, and for those with ARSS >-4 (-3~+4), the Confusion Assessment Method (CAM) is adopted for evaluation. A case consistent with delirium standard at any time point during follow up is determined to be delirium positive. Diagnosis should be confirmed for a CAM-positive patient by a psychological expert based on DSM-V standard	patient enrolled will be evaluated at 9Am and 3Pm during post-operative day 1-3 (POD1-3).At any time point above,delirium is detected,then the patient will be diagnosed as postoperative delirium. All patients enrolled is Non-delirium before surgery?
Secondary	Consumption of analgesic	the patients will receive patient-controlled intravenous analgesia,record the consumption of intravenous analgesia in the 48 postoperative hours	record the data of comsumption of analgeisic at 48 hours after operation
Secondary	Times of intra-operative occurrence of hypotension, bradycardia, hypertension and tachycardia that need treatment.	assess the adverse effect of anaesthetic	during the operation
Secondary	Score of quality of post-operative sleeping	Score of sleeping quality is evaluated based on the some questions during follow up	quality of sleeping will be assessed at 9Am during post-operative day 1-3
Secondary	Hospital stay	the duration from the day of operation to the date meeting discharge criteria as determined by doctor in charge	record the days of hospital stay at the 30 days after surgery
Secondary	Post-operative complications besides delirium	complications besides delirium ,such as vomiting,nausea,hypotention,hypertention,bradycardia	observe and evaluate complications at the 30 days after surgery
Secondary	Mortality up to day 30 post to operation	Data for 30-day survival is collected through telephone follow up by the assistant.	the data will be collected after 30 days of operation
Secondary	pain score	describe severity of the pain the patient feel using Numerical Rating Scale (NRS)	Pain score will be evaluated at time point of operation, 1,6,24, 48 hours after operation, using NRS score